We have proposed that human liver CD56+ T cells but not Vα24+ T cells are functional counterpart of mouse liver NKT (Vα14+) cells [2], [33], [34], and CD56+ T cells with a potent FasL producing capacity [33], [35] may also be involved in NASH. This evidence concerns the gene FASLG and metabolic dysfunction-associated steatohepatitis.